Sunil Singh

Sunil Singh is a results-driven scientist specializing in Antibody Therapeutics, currently serving as a Senior Scientist at Moderna. Sunil has extensive experience in antibody discovery, structural biology, and oncology drug development, with a focus on bi-specific and multi-specific antibody engineering. Previously, Sunil worked as a Postdoctoral Scientist at Biogen, where they optimized antibody discovery processes, and as a Teaching Assistant at the National University of Singapore, where they instructed students in laboratory techniques. Sunil holds a Master of Science in Biochemical Engineering and Biotechnology from the Indian Institute of Technology, Delhi, and a Ph.D. in Biological Sciences from the National University of Singapore.